Hankin Group – Speculative Lab Building

Precis provided architecture and engineering master planning services to Hankin Group, a family-owned real estate development firm, for a three-story, multi-tenant speculative laboratory building for multiple life science tenants involved in the drug discovery process from laboratory-based research through early stage (pilot scale) manufacturing.

The building will be located on a prominent site at the entrance to Eagleview, a mixed-use development community, located in the Philadelphia suburb of Exton, Pennsylvania.

Single- and multi-tenant concept layouts were developed for general research, gene and cell therapy, therapeutics, and contract research organizations. The building’s floor plate accommodates requirements for physical segregation, chain of custody, and biosafety level (BSL) segregation of suites, waste streams, and product flows.

The proposed site totals ~17.8 acres. Grading allows for basement level access on the building’s south side. Floor plates, excluding the basement, range from 40,000 to 43,500 sf each.